IDG-Accel China Growth Fund
6
11M
5
0.38
1
0.17
2
- Areas of investment
Summary
In 2005 was created IDG-Accel China Growth Fund, which is appeared as VC. The leading representative office of defined VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
Opposing the other organizations, this IDG-Accel China Growth Fund works on 11 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015. The top amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.
We can highlight the next thriving fund investment areas, such as Shipping, Apps. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Jiguang, Liulishuo
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the IDG-Accel China Growth Fund, startups are often financed by Social Starts, GGV Capital, Cherubic Ventures. The meaningful sponsors for the fund in investment in the same round are Mandra Capital, Trustbridge Partners, Sumavision. In the next rounds fund is usually obtained by Wu Capital, Genesis Ventures, Trustbridge Partners.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.38
- Follow on index
- 0.17
- Investments by industry
- Analytics (2)
- Risk Management (2)
- Financial Services (2)
- FinTech (2)
- Wireless (1) Show 12 more
- Investments by region
-
- China (5)
- United States (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Shenogen Pharma Group | 05 Aug 2013 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 20M | Beijing, Dongcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.